Mednow Inc News - MNOW

Professional-Grade Tools, for Individual Investors.

Suspension de la négociation par l'OCRCVM - MNOW

Suspension de la négociation par l'OCRCVM - MNOW Canada NewsWire VANCOUVER, BC, le 24 avril 2023 VANCOUVER, BC, le 24 avril 2023 /CNW/...

IIROC Trading Halt - MNOW

IIROC Trading Halt - MNOW Canada NewsWire VANCOUVER, BC, April 24, 2023 VANCOUVER, BC, April 24, 2023 /CNW/ - The following issues have been...

Mednow announces PBAS partnership.

Mednow to become the preferred virtual pharmacy partner for participating PBAS clients and their members. Prudent Benefits Administration...

Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q

Q2’23 revenue increased approximately 17% quarter-over-quarter to $11.3 million, and approximately 466% year-over-year; Mednow patient count...

PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION AND FILE FILING STATEMENT

PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION...

Mednow Inc. to Present at the Gravitas 6th Annual Growth Conference

Mednow Inc. (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it will be presenting at the Gravitas 6th...

Mednow releases Caregiver feature suite in its latest product update for the company’s web, IOS and Android applications; Mednow announces completion of Convertible Debenture Financing

The largest product release for the company’s virtual pharmacy platform to-date, targets a key and growing target problem in Canada; the...

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Virtual pharmacy care program provides convenient access to Dexcom G6 rtCGM supplies and diabetes management support services Mednow Inc...

Mednow Supports Expanded Scope of Practice for Ontario Pharmacists

Ontario pharmacists can now assess and prescribe for 13 minor ailments Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual...

Mednow Achieves Record Q1 2023 Financial Results with Quarterly Revenue of $9.7 Million; 35% Q/Q Revenue Growth and 1,300% Y/Y Revenue Growth; Costs Down 30% and Cash Flow from Operations Improved by 38% Q/Q

Q1’23 revenue increased approximately 35% quarter-over-quarter to $9.7 million, and approximately 1,300% year-over-year; Mednow patient count...

Mednow to Host Quarterly Conference Call on Wednesday January 18, 2023, at 8:30am EST on its First-Quarter 2023 Financial Results

Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its...

Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth

Q4/22 revenue increased over 11% quarter-over-quarter, and more than 5,700% year-over-year; Mednow patient count increased quarter over quarter...

Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results

Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its...

Mednow Opens Alberta Pharmacy Location

Extends Mednow’s growing national infrastructure and presence, demonstrating Mednow’s deep commitment to meeting patients where they are to...

An Open Letter to Mednow Investors

Mednow Co-Founder and CEO Ali Reyhany shares key financial results and indicators, recaps accomplishments and adds context on the macroeconomic...

Pennyes 2 years ago

Wow....On a tiny tiny thin, low float and a Pharma/med stock, no one is looking at the stock and company's revenues?....Not on your radar, soon your going to be shocked how far this lil co is going to fly high!!!..

todays volume is quite interesting!!!
are the MMs buying low to sell high later or is it banks buying, whoever is accumulating today, going to make tons of dough!

👍️0

Pennyes 3 years ago

Good Starter and the time is "Now"!!
Target price $2! short term price estimate... Long term: $5-10

Profits and Revenues Up!!
Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth and 4,800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Mednow Inc (MNOW)

Professional-Grade Tools, for Individual Investors.

MNOW News

Suspension de la négociation par l'OCRCVM - MNOW

IIROC Trading Halt - MNOW

Mednow announces PBAS partnership.

Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q

PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION AND FILE FILING STATEMENT

Mednow Inc. to Present at the Gravitas 6th Annual Growth Conference

Mednow releases Caregiver feature suite in its latest product update for the company’s web, IOS and Android applications; Mednow announces completion of Convertible Debenture Financing

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Mednow Supports Expanded Scope of Practice for Ontario Pharmacists

Mednow Achieves Record Q1 2023 Financial Results with Quarterly Revenue of $9.7 Million; 35% Q/Q Revenue Growth and 1,300% Y/Y Revenue Growth; Costs Down 30% and Cash Flow from Operations Improved by 38% Q/Q

Mednow to Host Quarterly Conference Call on Wednesday January 18, 2023, at 8:30am EST on its First-Quarter 2023 Financial Results

Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth

Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results

Mednow Opens Alberta Pharmacy Location

An Open Letter to Mednow Investors

MNOW Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Mednow Inc (MNOW) News

Mednow Inc (MNOW)

Professional-Grade Tools, for Individual Investors.

MNOW News

Suspension de la négociation par l'OCRCVM - MNOW

IIROC Trading Halt - MNOW

Mednow announces PBAS partnership.

Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q

PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION AND FILE FILING STATEMENT

Mednow Inc. to Present at the Gravitas 6th Annual Growth Conference

Mednow releases Caregiver feature suite in its latest product update for the company’s web, IOS and Android applications; Mednow announces completion of Convertible Debenture Financing

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Mednow Supports Expanded Scope of Practice for Ontario Pharmacists

Mednow Achieves Record Q1 2023 Financial Results with Quarterly Revenue of $9.7 Million; 35% Q/Q Revenue Growth and 1,300% Y/Y Revenue Growth; Costs Down 30% and Cash Flow from Operations Improved by 38% Q/Q

Mednow to Host Quarterly Conference Call on Wednesday January 18, 2023, at 8:30am EST on its First-Quarter 2023 Financial Results

Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth

Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results

Mednow Opens Alberta Pharmacy Location

An Open Letter to Mednow Investors

MNOW Discussion

Your Recent History

Go Ad-Free